←
Nathan Singh293 posts
Nathan Singh avatar

Nathan Singh

@NathanSinghLab

Using immunology, genomics and structural biology to engineer smarter cellular immunotherapies for cancer.

◷ Joined April 2019▧ 11 Photos and videos
Nathan Singh avatar
Nathan Singh@NathanSinghLab·Jan 16

Returning to Twitter (brielfy) to share publication of our article "BACH2 regulates T cell lineage state to enhance CAR T cell function" today in Nature Immunology! rdcu.be/eZlwj 1 of 3 studies (!) (others led by @RoychoudhuriLab and Tuoqi Wu) published together that...

Nathan Singh avatar
Nathan Singh@NathanSinghLab·Jan 16

identify the central role of BACH2 in T cell lineage decisions and function. A real pleasure working with the NI team and these great investigators! A great example complementary instead of competitive work strengthening the observation!

Nathan Singh avatar
Nathan Singh@NathanSinghLab·31 Oct 2024

Cell Therapy Keystone 2025 is coming! If you're interested in cell engineering, immunotherapy, cancer or autoimmunity (!) this meeting is for you! Join us in Banff for a fantastic symposium this March. Abstract deadline 12/9! @lab_rezvani keystonesymposia.org/confere…

Eric Holder avatar
⟳ Nathan Singh retweeted
Eric Holder@EricHolder·15 Sep 2024

There is no cavalry coming. No miracle solution. No saviors. In the end, we, the American people-not any of our institutions-have to save our democracy by registering and voting in defense of our freedoms the next two months. We are the cavalry. The responsibility is ours.

Nathan Singh avatar
Nathan Singh@NathanSinghLab·28 Aug 2024

Looking for a small meeting with leaders in cell therapy discussing high impact translational research? Look no further! The UChicago Jonas Center Symposium is for you! Please get in touch if you're interested or, better yet, register and join us! cme.uchicago.edu/JCCTS2024

Nathan Singh avatar
Nathan Singh@NathanSinghLab·22 Jul 2024

Taken the day @JoeBiden announced his candidacy in 2019. A patriot that history will remember for doing the right, hard thing, over and over. We are lucky to have had him as President. Now, let's kick it into gear for @VP @KamalaHQ and finish this!

Post attachment
Nathan Singh avatar
Nathan Singh@NathanSinghLab·9 Jul 2024

Using advanced modeling tools, we alleviated these conflicts to enhance receptor function across a variety of tumor models. A clear demonstration that design of synthetic immunotherapies requires consideration of de novo protein structures. (3/4)

Nathan Singh avatar
Nathan Singh@NathanSinghLab·9 Jul 2024

In our first foray into structural biology, we demonstrate that MHC-independent TCRs are riddled with structural and biochemical conflicts at hybrid domain interfaces, profoundly limiting function. (2/4)